Emergent BioSolutions to Release Fourth Quarter and Full Year 2012 Financial Results and Conduct a Conference Call on March 7,

  Emergent BioSolutions to Release Fourth Quarter and Full Year 2012 Financial
  Results and Conduct a Conference Call on March 7, 2013

Business Wire

ROCKVILLE, Md. -- February 1, 2013

Emergent BioSolutions Inc. (NYSE: EBS) announced today that it will report
financial results for the fourth quarter and full year 2012 on Thursday, March
7, 2013, after market close.

Company management will host a conference call at 5:00 pm Eastern on March 7,
2013 to discuss the financial results for the fourth quarter and full twelve
months of 2012, recent business developments, revenue guidance for the first
quarter of 2013 and revenue and net income guidance for full year 2013. The
conference call will be accessible by dialing 888/679-8038 or 617/213-4850
(international) and providing passcode 76232628. A webcast of the conference
call will be accessible from the company’s website at
www.emergentbiosolutions.com, under “Investors”.

Emergent BioSolutions is offering call participants a pre-registration option
that expedites access to the call and minimizes hold times. Pre-registrants
will be issued a pin number to be used when dialing into the live call which
will provide quick access to the conference call by bypassing the operator
upon connection. Pre-registration, while not mandatory, can be accessed using
the following website:
https://www.theconferencingservice.com/prereg/key.process?key=PQUQKA7V3.

A replay of the conference call will be accessible, approximately two hours
following the conclusion of the call, by dialing 888/286-8010 or 617/801-6888
and using the passcode 28122043. The replay will be available through March
21, 2013. The webcast will be archived on the company’s website,
www.emergentbiosolutions.com, under “Investors”.

About Emergent BioSolutions Inc.

Emergent BioSolutions is a specialty pharmaceutical company seeking to protect
and enhance life by offering specialized products to healthcare providers and
governments to address medical needs and emerging health threats. Additional
information about us may be found at www.emergentbiosolutions.com.

Follow us on twitter: @emergentbiosolu.

Contact:

Emergent BioSolutions Inc.
Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
301-795-1877
BurrowsR@ebsi.com
or
Media Contact:
Tracey Schmitt
Vice President, Corporate Communications
301-795-1800
SchmittT@ebsi.com
 
Press spacebar to pause and continue. Press esc to stop.